Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02549209
Title Pembro/Carbo/Taxol in Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mario Javier Pineda, MD
Indications

endometrial carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.